Vimarsana
Biggest News Aggregation in the World

Page 19 - Lead Managers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lead Managers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lead Managers Today - Breaking & Trending Today

OYO files IPO to raise $1.2 billion - Vimarsana News

OYO files IPO to raise $1.2 billion

Global travel technology company, OYO (Oravel Stays Limited) has filed its draft red herring prospectus (DRHP) for its initial public offering (IPO) of Rs 8,430

OYO files IPO to raise $1.2 billion - Vimarsana News

OYO files IPO to raise $1.2 billion

Global travel technology company, OYO (Oravel Stays Limited) has filed its draft red herring prospectus (DRHP) for its initial public offering (IPO) of Rs 8,430

OYO files IPO to raise $1.2 billion - Vimarsana News

OYO files IPO to raise $1.2 billion

Global travel technology company, OYO (Oravel Stays Limited) has filed its draft red herring prospectus (DRHP) for its initial public offering (IPO) of Rs 8,430

Freddie Mac Prices $1 Billion Multifamily K-Deal, K-129 - Vimarsana News

Freddie Mac Prices $1 Billion Multifamily K-Deal, K-129

Freddie Mac Prices $1 Billion Multifamily K-Deal, K-129 MCLEAN, Va., June 10, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are backed by underlying collateral consisting of fixed-rate multifamily mortgages with predominantly 10-year terms. The company expects to issue approximately $1 billion in K Certificates (K-129 Certificates), which are expected to settle on or about June 17, 2021. K-129 Pricing Co-Lead Managers and Joint Bookrunners: Morgan Stanley & Co. LLC and Credit Suisse Securities...

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Vimarsana News

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Creso Announced That its Total Q1 2021 Revenue Was A$1,385,000 – up 237% From Q4 2020 Creso Pharma (ASX: CPH) (OTC:COPHF) (FRA: 1X8) announced the release of its Quarterly Activities Report for the period ended 31 March 2021, together with its Appendix 4C Quarterly Cash Flow Report. “This quarter marked Creso’s evolution into a broader-based pharmaceutical company. Having undertaken a thorough search for quality, complementary acquisition opportunities, the company successfully identified and secured an agreement with psychedelics company, Halucenex, which, if approved by shareholders,...